Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Irina Nordkin; Tatyana Levinas; Inna Rosenfeld; Majdi Halabi

doi:10.1002/ccr3.3539

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Irina Nordkin
, Tatyana Levinas
, Inna Rosenfeld
, Majdi Halabi

Bar-Ilan University - Azrieli Faculty of Medicine

Rebecca Sieff Government Hospital
Bar-Ilan University

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

Original language	English
Pages (from-to)	391-394
Number of pages	4
Journal	Clinical Case Reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1002/ccr3.3539
State	Published - Jan 2021

Bibliographical note

Publisher Copyright:
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Keywords

QT prolongation
amiodarone
atrial fibrillation
torsades de Pointes

Access to Document

10.1002/ccr3.3539

Cite this

@article{ac0d0a86afe74c728c6de35bb990e66f,

title = "Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation",

abstract = "Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.",

keywords = "QT prolongation, amiodarone, atrial fibrillation, torsades de Pointes",

author = "Irina Nordkin and Tatyana Levinas and Inna Rosenfeld and Majdi Halabi",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Clinical Case Reports published by John Wiley \& Sons Ltd.",

year = "2021",

month = jan,

doi = "10.1002/ccr3.3539",

language = "אנגלית",

volume = "9",

pages = "391--394",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

AU - Nordkin, Irina

AU - Levinas, Tatyana

AU - Rosenfeld, Inna

AU - Halabi, Majdi

PY - 2021/1

Y1 - 2021/1

N2 - Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

AB - Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

KW - QT prolongation

KW - amiodarone

KW - atrial fibrillation

KW - torsades de Pointes

UR - https://www.scopus.com/pages/publications/85096688195

U2 - 10.1002/ccr3.3539

DO - 10.1002/ccr3.3539

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 33489188

AN - SCOPUS:85096688195

SN - 2050-0904

VL - 9

SP - 391

EP - 394

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 1

ER -

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this